Literature DB >> 3302134

Characterization of in vivo chemistry of cations in the heart.

S A Mousa, S J Williams, H Sands.   

Abstract

A variety of laboratory procedures can be used to define the chemistry and pharmacokinetics of myocardial cationic imaging agents. These methods are utilized to define the in vivo chemistry of cationic heart agents, in order to understand the kinetics and mechanisms of: tissue and cellular transport, subcellular distribution, and intracellular localization. Transport across cell membranes can be active, passive or facilitated. Studies performed in erythrocytes, heart cells, slices and isolated perfused hearts using methods for separation of metabolites have shown a high degree of myocardial specificity for [99mTc]hexakis alkyl isonitrile by an uptake mechanism different from 201Tl. These studies demonstrate the importance of in vivo chemistry and pharmacokinetics in the development of new radiopharmaceuticals.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3302134

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  8 in total

1.  The birth of a new radiopharmaceutical. Industrial perspective: from IND to NDA.

Authors:  L P Giering; J E Smith
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

Review 2.  Radionuclide targeting and dosimetry at the microscopic level: the role of microautoradiography.

Authors:  M R Puncher; P J Blower
Journal:  Eur J Nucl Med       Date:  1994-12

3.  Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization.

Authors:  E A Platts; T L North; R D Pickett; J D Kelly
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

4.  Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat heart mitochondria.

Authors:  A Younès; J A Songadele; J Maublant; E Platts; R Pickett; A Veyre
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

5.  The significance of a dipyridamole induced 99mTc-MIBI perfusion abnormality on single photon emission tomography: a quantitative validation with labelled water and positron emission tomography.

Authors:  E Rechavia; A R Galassi; L I Araujo; P Halson; A A Lammertsma; T Jones; J P Lavender; A Maseri
Journal:  Eur J Nucl Med       Date:  1992

6.  A comparison of rest sestamibi and rest-redistribution thallium single photon emission tomography: possible implications for myocardial viability detection in infarcted patients.

Authors:  M Dondi; F Tartagni; F Fallani; S Fanti; M Marengo; I DiTommaso; Q F Zheng; N Monetti
Journal:  Eur J Nucl Med       Date:  1993-01

7.  Effect of mitochondrial viability and metabolism on technetium-99m-sestamibi myocardial retention.

Authors:  P Crane; R Laliberté; S Heminway; M Thoolen; C Orlandi
Journal:  Eur J Nucl Med       Date:  1993-01

8.  Effectiveness of Tc-99m MIBI scintigraphy in diagnosing lung cancer.

Authors:  S Tanaka; T Asao; M Ubukata; H Sugiyama; Y Yajima; S Takenoshita; Y Nagamachi
Journal:  Surg Today       Date:  1997       Impact factor: 2.540

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.